{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:34:29Z","timestamp":1777606469807,"version":"3.51.4"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/hczj5883","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:09:46Z","timestamp":1714453786000},"page":"1165-1176","source":"Crossref","is-referenced-by-count":4,"title":["Elabela mitigates the early stage of inflammation in sepsis by inhibiting pyroptosis"],"prefix":"10.62347","volume":"16","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL and Dellinger RP. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43: 304-377.","journal-title":"Intensive Care Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL and Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395: 200-211.","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari M","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD and Singer M; Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 775-787.","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ and Angus DC. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 762-774.","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J and Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47: 1181-1247.","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4274\/balkanmedj.2017.0246","article-title":"Tumour necrosis factor-alpha and nuclear factor-kappa B gene variants in sepsis","volume":"35","author":"Acar","year":"2018","unstructured":"Acar L, Atalan N, Karagedik EH and Ergen A. Tumour necrosis factor-alpha and nuclear factor-kappa B gene variants in sepsis. Balkan Med J 2018; 35: 30-35.","journal-title":"Balkan Med J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2213-2600(20)30411-2","article-title":"Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial","volume":"9","author":"Eisen","year":"2021","unstructured":"Eisen DP, Leder K, Woods RL, Lockery JE, McGuinness SL, Wolfe R, Pilcher D, Moore EM, Shastry A, Nelson MR, Reid CM, McNeil JJ and McBryde ES. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. Lancet Respir Med 2021; 9: 186-195.","journal-title":"Lancet Respir Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","article-title":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis","volume":"10","author":"Karakike","year":"2019","unstructured":"Karakike E and Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol 2019; 10: 55.","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1348-0421.12771","article-title":"Inflammasome-associated cell death: pyroptosis, apoptosis, and physiological implications","volume":"64","author":"Tsuchiya","year":"2020","unstructured":"Tsuchiya K. Inflammasome-associated cell death: pyroptosis, apoptosis, and physiological implications. Microbiol Immunol 2020; 64: 252-269.","journal-title":"Microbiol Immunol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X, Li Z, Wang Y, Zhao Q, Shao F and Ding J. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell 2020; 180: 941-955, e920.","DOI":"10.1016\/j.cell.2020.02.002"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F and Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526: 660-665.","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imm.13320","article-title":"Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease","volume":"163","author":"AA","year":"2021","unstructured":"Patel AA, Ginhoux F and Yona S. Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease. Immunology 2021; 163: 250-261.","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/toddler is an endogenous agonist of the Apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","unstructured":"Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ, Carpenter TA, Glen RC, Morrell NW, Maguire JJ and Davenport AP. Elabela\/toddler is an endogenous agonist of the Apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 2017; 135: 1160-1173.","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","unstructured":"Chng SC, Ho L, Tian J and Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013; 27: 672-680.","journal-title":"Dev Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","unstructured":"Yang P, Maguire JJ and Davenport AP. Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends Pharmacol Sci 2015; 36: 560-567.","journal-title":"Trends Pharmacol Sci"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Coquerel D, Chagnon F, Sainsily X, Dumont L, Murza A, Côté J, Dumaine R, Sarret P, Marsault É, Salvail D, Auger-Messier M and Lesur O. ELABELA improves cardio-renal outcome in fatal experimental septic shock. Crit Care Med 2017; 45: e1139-e1148.","DOI":"10.1097\/CCM.0000000000002639"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.aam6607","article-title":"ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice","volume":"357","author":"Ho","year":"2017","unstructured":"Ho L, van Dijk M, Chye STJ, Messerschmidt DM, Chng SC, Ong S, Yi LK, Boussata S, Goh GH, Afink GB, Lim CY, Dunn NR, Solter D, Knowles BB and Reversade B. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science 2017; 357: 707-713.","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41419-020-02912-0","article-title":"ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway","volume":"11","author":"Chen","year":"2020","unstructured":"Chen Z, Wu C, Liu Y, Li H, Zhu Y, Huang C, Lin H, Qiao Q, Huang M, Zhu Q and Wang L. ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway. Cell Death Dis 2020; 11: 698.","journal-title":"Cell Death Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL and Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-10.","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","article-title":"Immunodesign of experimental sepsis by cecal ligation and puncture","volume":"4","author":"Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA and Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36.","journal-title":"Nat Protoc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","article-title":"International consensus criteria for pediatric sepsis and septic shock","volume":"331","author":"LJ","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR, Argent AC, Menon K, Hall MW, Akech S, Albers DJ, Alpern ER, Balamuth F, Bembea M, Biban P, Carrol ED, Chiotos K, Chisti MJ, DeWitt PE, Evans I, Flauzino de Oliveira C, Horvat CM, Inwald D, Ishimine P, Jaramillo-Bustamante JC, Levin M, Lodha R, Martin B, Nadel S, Nakagawa S, Peters MJ, Randolph AG, Ranjit S, Rebull MN, Russell S, Scott HF, de Souza DC, Tissieres P, Weiss SL, Wiens MO, Wynn JL, Kissoon N, Zimmerman JJ, Sanchez-Pinto LN and Bennett TD; Society of Critical Care Medicine Pediatric Sepsis Definition Task Force. International consensus criteria for pediatric sepsis and septic shock. JAMA 2024; 331: 665-674.","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/SHK.0000000000001936","article-title":"Necroptosis, pyroptosis, ferroptosis in sepsis and treatment","volume":"57","author":"Qu","year":"2022","unstructured":"Qu M, Wang Y, Qiu Z, Zhu S, Guo K, Chen W, Miao C and Zhang H. Necroptosis, pyroptosis, ferroptosis in sepsis and treatment. Shock 2022; 57: 161-171.","journal-title":"Shock"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-019-1761-4","article-title":"Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome","volume":"10","author":"Sun","year":"2019","unstructured":"Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z, Zhang Z and Dai Z. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell Death Dis 2019; 10: 542.","journal-title":"Cell Death Dis"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Chen X, Wu R, Li L, Zeng Y, Chen J, Wei M, Feng Y, Chen G, Wang Y, Lin L, Luo H, Chen A, Zeng Z, He F, Bai Y, Zhang S, Han Y, Wang Z, Zhao X, Xiao W, Jiang Y and Gong S. Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. Immunity 2023; 56: 336-352, e339.","DOI":"10.1016\/j.immuni.2023.01.015"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Evavold CL, Hafner-Bratkovič I, Devant P, D’Andrea JM, Ngwa EM, Boršić E, Doench JG, LaFleur MW, Sharpe AH, Thiagarajah JR and Kagan JC. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell 2021; 184: 4495-4511, e4419.","DOI":"10.1016\/j.cell.2021.06.028"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/s41401-022-00875-w","article-title":"Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects","volume":"43","author":"Ye","year":"2022","unstructured":"Ye C, Geng Z, Zhang LL, Zheng F, Zhou YB, Zhu GQ and Xiong XQ. Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects. Acta Pharmacol Sin 2022; 43: 2573-2584.","journal-title":"Acta Pharmacol Sin"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"107601","DOI":"10.1016\/j.isci.2023.107601","article-title":"Elabela inhibits TRAF1\/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing","volume":"26","author":"Hong","year":"2023","unstructured":"Hong Y, Li J, Zhong Y, Yang S, Pei L, Huang Z, Chen X, Wu H, Zheng G, Zeng C, Wu H and Wang T. Elabela inhibits TRAF1\/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing. iScience 2023; 26: 107601.","journal-title":"iScience"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-3040-2_1","article-title":"Molecular mechanisms of pyroptosis","volume":"2641","author":"MJ","year":"2023","unstructured":"Anderson MJ, den Hartigh AB and Fink SL. Molecular mechanisms of pyroptosis. Methods Mol Biol 2023; 2641: 1-16.","journal-title":"Methods Mol Biol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/4\/ajtr0156435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:53:03Z","timestamp":1766022783000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/4\/ajtr0156435.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/hczj5883","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}